Concept Medical Receives Third US FDA’s IDE Approval for Its Magictouch – Sirolimus Coated Balloon in Small Vessel Indication
3 min read
Surat (Gujarat) [India], May 1: Concept Medical Inc. (CMI), a global leader in drug delivery devices, has received its third Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) for its novel Sirolimus-coated balloon, Magic Touch SCB, for the treatment of Small Vessels (SV) in coronary arteries. This milestone comes after CMI received IDE approvals for Magic Touch SCB to treat Coronary In-Stent Restenosis (ISR) in September 2022 and Magic Touch PTA to treat “Below the Knee” Peripheral Arterial Diseases (PAD) in February 2022.
Small vessel disease affects up to 30% of patients undergoing PCI, and revascularization of small vessels is challenging due to increased technical failure rates and an elevated risk of restenosis with PCI, which can result in repeated interventions. Small Vessel Disease is also a predictor of Major Adverse Cardiac Events (MACE). The IDE approval allows Concept Medical to conduct pivotal clinical studies to gather safety and effectiveness data for the Magic Touch Sirolimus Coated Balloon in small vessel coronary disease. This data will support a future pre-market approval (PMA) application in the USA, providing patients and physicians with an alternate product for the treatment of CAD.
The CE approved Magic Touch SCB is the world’s first Sirolimus-coated Balloon with extensive commercial usage in Europe, major markets of Asia, and the Middle Eastern markets, with over 100,000 patients treated with Magic Touch SCB in these markets. CMI has the distinction of developing the world’s first Sirolimus Coated Balloon and Drug-eluting stent, with over 114 granted patents for its drug delivery platforms. The company has even completed Clinical Trials in Japan, with an expected PMDA approval in Japan soon. These USFDA IDE approvals provide CMI with access to the US market.
Currently, there are no FDA approved Drug Coated Balloons for the treatment of CAD in the USA, and the patients are limited to the availability of Drug Eluting Stents and uncoated Balloons. MagicTouch has already been widely studied globally in multiple clinical trials, most notably the EASTBOURNE Registry (2123 patients), NANOLUTE, and ongoing trials like the TRANSFORM 1, TRANSFORM 2, GINGER, TITAN, and Hybrid Bifurcation DEB. Sirolimus has already proven to be safer in coronary artery disease treatment.
Notably, no Indian company has received IDE approval for a Drug-Coated Balloon in the USA, either in the Peripheral or Coronary indications. CMI’s innovation and success in obtaining three IDE approvals in different treatment indications highlight India’s research capabilities in the medical field. This achievement has the potential to be a game changer for the healthcare industry, healthcare professionals, and patients at large, providing with an alternate product for the treatment CAD & PAD.
Dr. Martin Leon, Founder of the Cardiovascular Research Foundation, will lead the coming IDE trials and stresses the importance of this achievement, stating, “The FDA-approval to initiate the MAGICAL -SV Clinical trial using the Magic Touch sirolimus-covered balloon with nanolute technology represents a landmark event in our decades-long quest to find an optimal therapy to manage patients with small vessel coronary obstructive disease.”
Dr Manish Doshi, founder and managing director of Concept Medical, expressed his appreciation for the approvals, stating, “We are deeply honored to receive three IDE approvals from the US FDA for our Sirolimus drug-coated balloons for the treatment of coronary and peripheral arterial diseases. This brings us closer to offering innovative treatment options to patients in the US and represents a significant leap in the field of Vascular Space for our flagship product, ‘Magic Touch,’ which is the world’s first Sirolimus Coated Balloon with roots in INDIA making the country proud.”
About MagicTouch SCB:
MagicTouch SCB is a CE marked and commercially marketed Sirolimus-coated balloon developed by Concept Medical, using proprietary Nanoluté Technology. MagicTouch SCB has been used in >50,000 patients in major global markets.
About Concept Medical Inc (CMI):
CMI is headquartered in Tampa, Florida, and has operational offices in The Netherlands, Singapore, and Brazil, with manufacturing units in India. CMI specializes in developing drug-delivery systems and has unique and patented technology platforms that can be deployed to deliver any drug/pharmaceutical agent across the luminal surfaces of blood vessels.
If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.
It’s going to be end of mine day, except before end I am reading this enormous piece of writing to increase my experience.
Have you ever thought about publishing an e-book or guest authoring on other sites? I have a blog based upon on the same ideas you discuss and would really like to have you share some stories/information. I know my visitors would enjoy your work. If you are even remotely interested, feel free to send me an e-mail.
Your style is so unique compared to other people I have read stuff from. Many thanks for posting when you have the opportunity, Guess I will just bookmark this site.
Thank you for the auspicious writeup. It if truth be told used to be a entertainment account it. Glance complex to far introduced agreeable from you! By the way, how can we communicate?
I like the valuable information you provide in your articles. I will bookmark your weblog and check again here frequently. I am quite certain I will learn plenty of new stuff right here! Good luck for the next!
Greetings from Ohio! I’m bored to tears at work so I decided to check out your website on my iphone during lunch break. I enjoy the info you present here and can’t wait to take a look when I get home. I’m amazed at how quick your blog loaded on my mobile .. I’m not even using WIFI, just 3G .. Anyhow, fantastic site!
Fantastic goods from you, man. I’ve understand your stuff previous to and you’re just too magnificent. I really like what you’ve acquired here, really like what you’re stating and the way in which you say it. You make it entertaining and you still take care of to keep it smart. I can not wait to read far more from you. This is actually a wonderful website.
Hi there it’s me, I am also visiting this website regularly, this website is really good and the users are really sharing pleasant thoughts.
I am sure this piece of writing has touched all the internet users, its really really good post on building up new website.
It’s really a nice and helpful piece of information. I’m satisfied that you shared this helpful info with us. Please stay us informed like this. Thank you for sharing.
Hi there, I enjoy reading all of your article. I like to write a little comment to support you.
Hi everyone, it’s my first go to see at this site, and article is in fact fruitful designed for me, keep up posting such articles or reviews.
Hi, Neat post. There is a problem with your site in internet explorer, may check this? IE still is the marketplace leader and a good portion of folks will miss your magnificent writing due to this problem.
It’s not my first time to visit this website, i am visiting this website dailly and get good information from here everyday.
Hi there everyone, it’s my first pay a visit at this web site, and article is actually fruitful designed for me, keep up posting such articles.
Woah! I’m really loving the template/theme of this site. It’s simple, yet effective. A lot of times it’s very hard to get that “perfect balance” between user friendliness and visual appeal. I must say you have done a excellent job with this. In addition, the blog loads very fast for me on Internet explorer. Superb Blog!
Oh my goodness! Awesome article dude! Thanks, However I am going through problems with your RSS. I don’t know why I can’t subscribe to it. Is there anyone else getting identical RSS problems? Anybody who knows the solution will you kindly respond? Thanx!!
Hi there to every one, it’s truly a nice for me to go to see this website, it consists of valuable Information.
Spot on with this write-up, I absolutely believe this web site needs a lot more attention. I’ll probably be back again to read through more, thanks for the info!
I don’t even know how I ended up here, but I thought this post was good. I don’t know who you are but definitely you are going to a famous blogger if you are not already 😉 Cheers!
hi!,I really like your writing so much! proportion we communicate more approximately your post on AOL? I need an expert in this space to solve my problem. May be that is you! Looking forward to peer you.
Hey there, I think your website might be having browser compatibility issues. When I look at your blog in Firefox, it looks fine but when opening in Internet Explorer, it has some overlapping. I just wanted to give you a quick heads up! Other then that, awesome blog!